Isofol Medical AB (ISOFOL) — Working Capital to Net Assets Ratio
Isofol Medical AB (ISOFOL) has a Working Capital to Net Assets ratio of 100.6% as of December 2025. Working capital of Skr108.48 Million (current assets of Skr129.40 Million minus current liabilities of Skr20.91 Million) is measured against net assets of Skr107.87 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See ISOFOL defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Isofol Medical AB Working Capital to Net Assets (2011–2025)
This chart shows how Isofol Medical AB's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 100.6%, reflecting working capital of Skr108.48 Million against net assets of Skr107.87 Million SEK. For the complete balance sheet picture, see ISOFOL total assets.
Annual Working Capital to Net Assets for Isofol Medical AB (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Isofol Medical AB from 2011 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Isofol Medical AB (ISOFOL) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.6% | Skr108.48 Million | Skr107.87 Million | Skr129.40 Million | Skr20.91 Million | ▼ -0.3 pp |
| 2024 | 100.8% | Skr78.59 Million | Skr77.94 Million | Skr98.42 Million | Skr19.82 Million | ▲ +0.1 pp |
| 2023 | 100.7% | Skr122.34 Million | Skr121.43 Million | Skr140.59 Million | Skr18.25 Million | ▲ +0.5 pp |
| 2022 | 100.3% | Skr158.91 Million | Skr158.48 Million | Skr209.45 Million | Skr50.54 Million | ▲ +2.4 pp |
| 2021 | 97.9% | Skr311.59 Million | Skr318.23 Million | Skr394.61 Million | Skr83.02 Million | ▲ +8.2 pp |
| 2020 | 89.7% | Skr59.72 Million | Skr66.57 Million | Skr139.84 Million | Skr80.12 Million | ▼ -3.9 pp |
| 2019 | 93.6% | Skr98.22 Million | Skr104.91 Million | Skr137.02 Million | Skr38.80 Million | ▼ -4.8 pp |
| 2018 | 98.5% | Skr260.92 Million | Skr265.01 Million | Skr284.46 Million | Skr23.54 Million | ▼ -1.4 pp |
| 2017 | 99.9% | Skr342.55 Million | Skr343.03 Million | Skr360.80 Million | Skr18.24 Million | ▲ +9.1 pp |
| 2016 | 90.8% | Skr5.54 Million | Skr6.10 Million | Skr22.33 Million | Skr16.79 Million | ▲ +37.7 pp |
| 2015 | 53.0% | Skr701.00K | Skr1.32 Million | Skr9.16 Million | Skr8.46 Million | ▼ -36.0 pp |
| 2011 | 89.0% | Skr7.02 Million | Skr7.89 Million | Skr9.51 Million | Skr2.49 Million | — |